Mouwasat Medical Services dividend and valuation

4002 · Tadawul · SAR

Compare Mouwasat Medical Services
SAR 56.50Change from previous close: −1.65%Absolute change: −SAR 0.95

Close · November 22, 2026

Valuation

Mouwasat Medical Services paid SAR 3.13 per share in dividends over the last 12 months (yield 5.5%). Last ex-dividend date: October 18, 2026. The P/E ratio is 13.5. The average price target of 13 analysts is SAR 75.92.

Data as of November 22, 2026

Mouwasat Medical Services compared with similar companies

Mouwasat Medical Services's P/E (trailing 12 months): 13.5, −51% against the median of a group of 10 similar companies (27.7).

Mouwasat Medical Services's metrics compared with similar companies
MetricMouwasat Medical ServicesMedian25th–75th percentileBand
P/E (trailing 12 months)13.527.712.6 – 39.6Middle
Forward P/E13.117.310.7 – 27.2Middle
EV/EBITDA10.913.29.79 – 26.3Middle
Price/book2.773.381.69 – 7.54Middle
Price/sales3.331.810.65 – 5.41Middle
Gross margin40.6%32.3%25.0% – 44.9%Middle
Operating margin25.8%10.9%8.2% – 17.9%High
Net margin24.3%7.0%3.9% – 12.8%High
ROE21.2%15.8%9.1% – 20.4%High
Debt/equity0.290.890.56 – 1.88Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Mouwasat Medical Services: valuation over time

On the latest fiscal year's earnings (2025), Mouwasat Medical Services's P/E today is 13.8, below the median of its last 10 fiscal years (26.2; between 16.2 and 34.9 from 2016 to 2025). Relative to earnings, the stock costs less than it used to. The dividend yield (5.5%) is above the median of the last 10 fiscal years (1.9%).

Mouwasat Medical Services P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
2025SAR 66.65SAR 4.1116.2SAR 2.133.2%
2024SAR 85.10SAR 3.2326.4SAR 2.002.4%
2023SAR 111.80SAR 3.2934.0SAR 1.751.6%
2022SAR 104.50SAR 3.0034.9SAR 1.501.4%
2021SAR 86.90SAR 2.8930.1SAR 1.381.6%
2020SAR 69.00SAR 2.6426.1SAR 1.251.8%
2019SAR 44.00SAR 2.1120.9SAR 1.002.3%
2018SAR 40.25SAR 1.8022.3SAR 0.882.2%
2017SAR 37.85SAR 1.6822.5SAR 0.752.0%
2016SAR 36.75SAR 1.2928.6SAR 0.631.7%

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
SAR 11.49B
Enterprise value
SAR 12.5B
PEG
2.42
EV/revenue
3.62

Profitability and growth

ROA
8.8%
ROIC
10.7%
Revenue growth (year over year)
10.2%
Earnings growth (year over year)
-5.8%

Financial health

Total cash
SAR 393.71M
Total debt
SAR 1.26B
Current ratio
1.72
Quick ratio
1.35
Altman Z-Score
4.91
Piotroski F-Score
5.00

Dividends

Annual dividend per share
SAR 3.13
Dividend yield
5.5%
Payout ratio
73.5%
Ex-dividend date
October 18, 2026

Analysts and estimates

Average price target
SAR 75.92
Median price target
SAR 70.00
High price target
SAR 100.00
Low price target
SAR 57.00
Analysts with a price target
13
Consensus
Buy
Forward EPS
SAR 4.39
EPS estimate, current year
SAR 4.22

Shares and trading

Beta
0.11
Average volume
357.8K
Shares outstanding
200M
Float
90.76M
Institutional ownership
5.4%
Insider ownership
51.9%